Amphetamine-induced increases in dopaminergic single cell firing rate after haloperidol pretreatment. Correlation with extrapyramidal side effects.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D003024:Clozapine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D005116:Extrapyramidal Tracts / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects*; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects; D013881:Thioridazine / Q000494:pharmacology
D003024:Clozapine; D006220:Haloperidol; D008787:Metoclopramide; D001058:Apomorphine; D013881:Thioridazine; D003913:Dextroamphetamine; D004298:Dopamine